Unlocking Opportunities in the Emphysema Treatment Market: Key Growth Trends and Forecast Insights
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Growth Potential of the Emphysema Treatment Market, and How Will It Perform by 2034?
The market for emphysema treatment has seen significant expansion in the past few years. The size of the market is set to increase from $5.15 billion in 2024 to $5.43 billion in 2025, with a compound annual growth rate (CAGR) of 5.6%. The considerable growth witnessed in the past is due to factors such as the impact of the smoking epidemic, advancements in medicine, the implementation of pulmonary rehabilitation programs, the development of better diagnostic tools, and increased awareness and education.
Looking ahead, the market size of emphysema treatments is set to experience significant growth in the upcoming years, projecting a rise to “$7.4 billion by 2029 with a compound annual growth rate (CAGR) of 8.0%. This expected surge during the forecast period is largely due to factors such as the increase in the aging population, personalization of treatment methods, better access to treatment options, attention to symptom management and the establishment of collaborative healthcare models. Key trends to look out for during this period range from the development of gene therapies and patient enlightenment and involvement to artificial intelligence (AI) incorporation, improved treatment accessibility, and the creation of long-acting medications.
What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the emphysema treatment Market?
The escalating incidence of Chronic Obstructive Pulmonary Disease (COPD) is anticipated to fuel the expansion of the emphysema treatment market. COPD encompasses conditions that result in airflow obstruction and trouble breathing, including emphysema and chronic bronchitis. Treatments for emphysema are crucial for mitigating COPD’s progression as they target symptoms, heal lung function, and slow the progression of the disease. For example, the Australian Institute of Health and Welfare (AIHW) reported in June 2024 that around 638,000 individuals, or 2.5% of the Australian population, were living with COPD in 2022. By 2023, COPD’s prevalence had increased to represent 3.6% of the total disease burden, accounting for 50% of the overall respiratory condition burden. Additionally, in 2022, COPD was the reason behind 7,691 deaths, translating to 29.6 deaths per 100,000 people, and making up 4.0% of all mortalities in the country. Hence, the growing predominance of COPD cases stimulates the emphysema treatment market.
Explore Comprehensive Insights Into The Global Emphysema Treatment Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp
Who Are the Major Companies Shaping the Competitive Landscape of the Emphysema Treatment Market?
Major companies operating in the emphysema treatment market include:
• AstraZeneca PLC_x000D_
• Teva Pharmaceutical Industries Ltd._x000D_
• Novartis AG_x000D_
• GlaxoSmithKline PLC_x000D_
• Hikma Pharmaceuticals PLC_x000D_
What Are the Key Emerging Trends in the Emphysema Treatment Market for the Next Decade?
Leading businesses in the emphysema market are creating minimally invasive processes to gain a strategic advantage. These are medical interventions or surgical methods which cause minimal damage to normal bodily structures. For example, in January 2022, Adena Health System, a healthcare company in the US, rolled out the Zephyr Valve surgery. This new minimally invasive technique presents an option aside from the traditional lung volume reduction surgery for those dealing with lung hyperinflation, a recurring problem in emphysema and COPD. This ground-breaking method involves the insertion of tiny, one-directional Zephyr Valves into the lung airways using a bronchoscope. These valves assist in releasing trapped air, stopping further build-up, and enabling healthier sections of the lung to enlarge, resulting in improved breathing.
Secure Your Global Emphysema Treatment Market Report Now for Fast and Efficient Delivery!
https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report
Which Key Segments Stand Out in Understanding the Composition of the Emphysema Treatment Market?
The emphysema treatment market covered in this report is segmented –
1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments
2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies
3) By End-User: Clinics, Surgical Centre, Other End-Users
Subsegments:
1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs
2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics
3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers
4) By Leukotriene Modifiers: Montelukast, Zafirlukast
5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems
6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines
7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides
8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation
9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care
Which Regions Are Making a Mark in the Emphysema Treatment Market Growth?
North America was the largest region in the emphysema treatment market in 2024. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Does the Definition of the Emphysema Treatment Market Include?
Emphysema treatment is a medication for chronic obstructive pulmonary disease (COPD) that causes damage to the lungs’ air sacs, making breathing difficult. Emphysema treatments are available to control symptoms and decrease disease development of emphysema.
Browse Through More Similar Reports By The Business Research Company:
Autoimmune Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report
Infertility Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report
Point Of Entry Water Treatment Systems Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
